• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

参与丁型肝炎病毒生命周期的细胞因子。

Cellular Factors Involved in the Hepatitis D Virus Life Cycle.

机构信息

Paul-Ehrlich-Institute, Department of Virology, D-63225 Langen, Germany.

出版信息

Viruses. 2023 Aug 3;15(8):1687. doi: 10.3390/v15081687.

DOI:10.3390/v15081687
PMID:37632029
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10459925/
Abstract

Hepatitis D virus (HDV) is a defective RNA virus with a negative-strand RNA genome encompassing less than 1700 nucleotides. The HDV genome encodes only for one protein, the hepatitis delta antigen (HDAg), which exists in two forms acting as nucleoproteins. HDV depends on the envelope proteins of the hepatitis B virus as a helper virus for packaging its ribonucleoprotein complex (RNP). HDV is considered the causative agent for the most severe form of viral hepatitis leading to liver fibrosis/cirrhosis and hepatocellular carcinoma. Many steps of the life cycle of HDV are still enigmatic. This review gives an overview of the complete life cycle of HDV and identifies gaps in knowledge. The focus is on the description of cellular factors being involved in the life cycle of HDV and the deregulation of cellular pathways by HDV with respect to their relevance for viral replication, morphogenesis and HDV-associated pathogenesis. Moreover, recent progress in antiviral strategies targeting cellular structures is summarized in this article.

摘要

丁型肝炎病毒 (HDV) 是一种缺陷型 RNA 病毒,其负链 RNA 基因组小于 1700 个核苷酸。HDV 基因组仅编码一种蛋白,即乙型肝炎病毒抗原 (HDAg),它有两种形式,作为核蛋白发挥作用。HDV 依赖乙型肝炎病毒的包膜蛋白作为辅助病毒来包装其核糖核蛋白复合物 (RNP)。HDV 被认为是导致最严重形式的病毒性肝炎的病原体,可导致肝纤维化/肝硬化和肝细胞癌。HDV 的许多生命周期步骤仍然是谜。本文概述了 HDV 的完整生命周期,并确定了知识空白。重点是描述参与 HDV 生命周期的细胞因子以及 HDV 对细胞途径的调控,因为这些与病毒复制、形态发生和与 HDV 相关的发病机制有关。此外,本文还总结了针对细胞结构的抗病毒策略的最新进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d171/10459925/9ee89ee592d2/viruses-15-01687-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d171/10459925/11b54bfa50e3/viruses-15-01687-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d171/10459925/55d509208e24/viruses-15-01687-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d171/10459925/cbdd852629b7/viruses-15-01687-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d171/10459925/e5ac9cedb87d/viruses-15-01687-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d171/10459925/9ee89ee592d2/viruses-15-01687-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d171/10459925/11b54bfa50e3/viruses-15-01687-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d171/10459925/55d509208e24/viruses-15-01687-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d171/10459925/cbdd852629b7/viruses-15-01687-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d171/10459925/e5ac9cedb87d/viruses-15-01687-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d171/10459925/9ee89ee592d2/viruses-15-01687-g005.jpg

相似文献

1
Cellular Factors Involved in the Hepatitis D Virus Life Cycle.参与丁型肝炎病毒生命周期的细胞因子。
Viruses. 2023 Aug 3;15(8):1687. doi: 10.3390/v15081687.
2
Future treatments for hepatitis delta virus infection.丁型肝炎病毒感染的未来治疗方法。
Liver Int. 2020 Feb;40 Suppl 1:54-60. doi: 10.1111/liv.14356.
3
Hepatitis Delta Virus Alters the Autophagy Process To Promote Its Genome Replication.乙型肝炎 Delta 病毒通过改变自噬过程促进其基因组复制。
J Virol. 2020 Jan 31;94(4). doi: 10.1128/JVI.01936-19.
4
Identification of a novel interaction site between the large hepatitis delta antigen and clathrin that regulates the assembly of genotype III hepatitis delta virus.鉴定一种新型的大庚型肝炎 delta 抗原和网格蛋白之间的相互作用位点,该位点调节 III 型庚型肝炎 delta 病毒的组装。
Virol J. 2022 Oct 17;19(1):163. doi: 10.1186/s12985-022-01866-3.
5
Casein kinase II and protein kinase C modulate hepatitis delta virus RNA replication but not empty viral particle assembly.酪蛋白激酶II和蛋白激酶C调节丁型肝炎病毒RNA复制,但不调节空病毒颗粒组装。
J Virol. 1996 Sep;70(9):6190-8. doi: 10.1128/JVI.70.9.6190-6198.1996.
6
Variable In Vivo Hepatitis D Virus (HDV) RNA Editing Rates According to the HDV Genotype.根据 HDV 基因型,体内 HDV RNA 编辑率存在差异。
Viruses. 2021 Aug 9;13(8):1572. doi: 10.3390/v13081572.
7
Hepatitis Delta Antigen Regulates mRNA and Antigenome RNA Levels during Hepatitis Delta Virus Replication.乙型肝炎 delta 抗原在乙型肝炎 delta 病毒复制过程中调节 mRNA 和抗原基因组 RNA 水平。
J Virol. 2019 Apr 3;93(8). doi: 10.1128/JVI.01989-18. Print 2019 Apr 15.
8
[Hepatitis delta virus replication and the role of the small hepatitis delta protein S-HDAg].[丁型肝炎病毒复制及丁型肝炎小蛋白S-HDAg的作用]
Med Sci (Paris). 2018 Oct;34(10):833-841. doi: 10.1051/medsci/2018209. Epub 2018 Nov 19.
9
Hepatitis D virus: an update.丁型肝炎病毒:更新。
Liver Int. 2011 Jan;31(1):7-21. doi: 10.1111/j.1478-3231.2010.02320.x. Epub 2010 Sep 29.
10
An update on HDV: virology, pathogenesis and treatment.丁型肝炎病毒最新进展:病毒学、发病机制与治疗
Antivir Ther. 2013;18(3 Pt B):541-8. doi: 10.3851/IMP2598. Epub 2013 Jun 21.

引用本文的文献

1
Updates on Recent Advancements in Hepatitis D Virus Treatment.丁型肝炎病毒治疗的最新进展
Viruses. 2025 Aug 10;17(8):1100. doi: 10.3390/v17081100.
2
Differential impact of hepatitis delta virus replication and expression of viral antigens on the cellular kinome profile.丁型肝炎病毒复制及病毒抗原表达对细胞激酶组谱的差异影响。
Cell Commun Signal. 2025 Jun 19;23(1):294. doi: 10.1186/s12964-025-02290-0.
3
Histopathological Features of Hepatocellular Carcinoma in Patients with Hepatitis B and D Virus Infection: A Single-Institution Study in Mongolia.

本文引用的文献

1
A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D.慢性丁型肝炎的布乐瑞肽 3 期随机临床试验。
N Engl J Med. 2023 Jul 6;389(1):22-32. doi: 10.1056/NEJMoa2213429. Epub 2023 Jun 22.
2
Hepatitis Delta Virus Antigens Trigger Oxidative Stress, Activate Antioxidant Nrf2/ARE Pathway, and Induce Unfolded Protein Response.丁型肝炎病毒抗原引发氧化应激,激活抗氧化Nrf2/ARE通路,并诱导未折叠蛋白反应。
Antioxidants (Basel). 2023 Apr 21;12(4):974. doi: 10.3390/antiox12040974.
3
Interactions of Na/taurocholate cotransporting polypeptide with host cellular proteins upon hepatitis B and D virus infection: novel potential targets for antiviral therapy.
乙型肝炎和丁型肝炎病毒感染患者肝细胞癌的组织病理学特征:蒙古一家机构的研究
Cancers (Basel). 2025 Jan 27;17(3):432. doi: 10.3390/cancers17030432.
4
Hepatitis B virus entry, assembly, and egress.乙型肝炎病毒的进入、组装和释放。
Microbiol Mol Biol Rev. 2024 Dec 18;88(4):e0001424. doi: 10.1128/mmbr.00014-24. Epub 2024 Oct 23.
5
Highlights from the 2023 International Meeting on the Molecular Biology of Hepatitis B virus.2023 年乙型肝炎病毒分子生物学国际会议要点。
J Gen Virol. 2024 May;105(5). doi: 10.1099/jgv.0.001978.
乙型肝炎和丁型肝炎病毒感染时牛磺胆酸钠共转运多肽与宿主细胞蛋白的相互作用:抗病毒治疗的新潜在靶点。
Biol Chem. 2023 Apr 28;404(7):673-690. doi: 10.1515/hsz-2022-0345. Print 2023 Jun 27.
4
Treating hepatitis D with bulevirtide - Real-world experience from 114 patients.使用布列韦肽治疗丁型肝炎——114例患者的真实世界经验。
JHEP Rep. 2023 Mar 15;5(4):100686. doi: 10.1016/j.jhepr.2023.100686. eCollection 2023 Apr.
5
Relevance of HBx for Hepatitis B Virus-Associated Pathogenesis.HBx 与乙型肝炎病毒相关发病机制的相关性。
Int J Mol Sci. 2023 Mar 4;24(5):4964. doi: 10.3390/ijms24054964.
6
Hepatitis D virus interferes with hepatitis B virus RNA production via interferon-dependent and -independent mechanisms.丁型肝炎病毒通过依赖干扰素和不依赖干扰素的机制干扰乙型肝炎病毒RNA的产生。
J Hepatol. 2023 May;78(5):958-970. doi: 10.1016/j.jhep.2023.01.005. Epub 2023 Jan 24.
7
A stable hepatitis D virus-producing cell line for host target and drug discovery.用于宿主靶点和药物发现的稳定产生丁型肝炎病毒的细胞系。
Antiviral Res. 2023 Jan;209:105477. doi: 10.1016/j.antiviral.2022.105477. Epub 2022 Nov 26.
8
Identification of a novel interaction site between the large hepatitis delta antigen and clathrin that regulates the assembly of genotype III hepatitis delta virus.鉴定一种新型的大庚型肝炎 delta 抗原和网格蛋白之间的相互作用位点,该位点调节 III 型庚型肝炎 delta 病毒的组装。
Virol J. 2022 Oct 17;19(1):163. doi: 10.1186/s12985-022-01866-3.
9
Presence of Intact Hepatitis B Virions in Exosomes.乙肝病毒在 exosomes 中的存在。
Cell Mol Gastroenterol Hepatol. 2023;15(1):237-259. doi: 10.1016/j.jcmgh.2022.09.012. Epub 2022 Sep 30.
10
Bulevirtide and tenofovir combination therapy for hepatitis D virus infection: longer treatment and more diverse trial populations are needed.布列韦迪与替诺福韦联合治疗丁型肝炎病毒感染:需要更长疗程治疗及更多样化的试验人群。
Lancet Infect Dis. 2023 Jan;23(1):14-16. doi: 10.1016/S1473-3099(22)00412-1. Epub 2022 Sep 13.